Greenleaf Trust reduced its stake in shares of Shire PLC (NASDAQ:SHPG) by 3.5% during the second quarter, Holdings Channel reports. The firm owned 1,307 shares of the biopharmaceutical company’s stock after selling 48 shares during the period. Greenleaf Trust’s holdings in Shire PLC were worth $241,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SHPG. Duncker Streett & Co. Inc. bought a new position in Shire PLC during the second quarter valued at approximately $111,000. Quadrant Capital Group LLC raised its stake in shares of Shire PLC by 157.6% in the second quarter. Quadrant Capital Group LLC now owns 608 shares of the biopharmaceutical company’s stock worth $101,000 after buying an additional 372 shares during the last quarter. West Oak Capital LLC acquired a new stake in shares of Shire PLC during the second quarter worth about $126,000. NEXT Financial Group Inc acquired a new stake in shares of Shire PLC during the second quarter worth about $126,000. Finally, North Star Investment Management Corp. acquired a new stake in shares of Shire PLC during the second quarter worth about $147,000. 24.26% of the stock is currently owned by institutional investors.
Shire PLC (NASDAQ:SHPG) traded up 0.49% during midday trading on Friday, hitting $194.50. The stock had a trading volume of 614,063 shares. The stock’s 50 day moving average price is $195.68 and its 200-day moving average price is $186.83. Shire PLC has a 52 week low of $147.60 and a 52 week high of $231.32. The company has a market cap of $57.93 billion, a PE ratio of 40.42 and a beta of 1.16.
Shire PLC (NASDAQ:SHPG) last released its earnings results on Tuesday, August 2nd. The biopharmaceutical company reported $3.38 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.03 by $0.35. The firm earned $2.43 million during the quarter, compared to analyst estimates of $2.28 billion. Shire PLC had a net margin of 13.19% and a return on equity of 17.70%. The business’s revenue was up 55.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.63 EPS. Equities research analysts predict that Shire PLC will post $12.92 earnings per share for the current year.
The business also recently disclosed a dividend, which will be paid on Friday, October 7th. Stockholders of record on Friday, September 9th will be given a dividend of $0.139 per share. The ex-dividend date of this dividend is Wednesday, September 7th. Shire PLC’s dividend payout ratio is currently 15.63%.
A number of brokerages have recently issued reports on SHPG. Piper Jaffray Cos. set a $201.00 target price on Shire PLC and gave the stock a “hold” rating in a research report on Saturday, October 1st. Leerink Swann reaffirmed a “buy” rating on shares of Shire PLC in a research report on Saturday, October 1st. Citigroup Inc. reaffirmed a “buy” rating on shares of Shire PLC in a research report on Wednesday, August 3rd. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Shire PLC in a research report on Wednesday, June 15th. Finally, Shore Capital reaffirmed a “buy” rating on shares of Shire PLC in a research report on Tuesday, June 14th. Five investment analysts have rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $232.75.
Shire PLC Company Profile
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.